醫療團隊
專業的醫護人員，提供最佳的醫療服務
醫師介紹
李信賦醫師
心臟血管疾病、介入性心導管治療、心臟血管超音波、週邊血管超音波
- 國語,英語,閩南語
- 助理教授
醫師資歷
-
現職
- 新北市立土城醫院內科部副部長
- 新北市立土城醫院心臟內科副教授級主治醫師/科主任
- 長庚大學兼任助理教授
-
學歷
- 長庚大學臨床研究所博士班進修
- 長庚大學中西醫雙主修學士
-
經歷
- 林口長庚心臟內科副教授級主治醫師
- 林口長庚心臟內一科主治醫師
- 林口長庚心臟內一科住院醫師
- 林口長庚內科部住院醫師
-
學會與認證
- 中華民國內科專科醫師
- 台灣介入性心臟血管醫學會會員
- 中華民國心臟學會心臟血管介入專科醫師
- 中華民國心臟學會專科醫師
-
論文及期刊發表
- 僅列以第一作者或通訊作者身份所發表的文章
- Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor
Cardiovasc Diabetol. 2020;19:160
Lee HF,et al. - Direct Oral Anticoagulants in Atrial Fibrillation Patients with Concomitant Hyperthyroidism.
J Clin Endocrinol Metab. 2020.
Lee HF - Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort Study.
Can J Cardiol. 2020
Lee HF,et al. - Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Atrial Fibrillation Patients with Concomitant Peripheral Artery Disease
Eur Heart J Cardiovasc Pharmacother. 2019.
Lee HF,et al. - Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
Chest. 2019 May 16. pii: S0012-3692(19)31056-6. doi: 10.1016/j.chest.2019.04.108
Chan YH, Lee HF(co-first author),et al. - Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation.J Am Heart Assoc
2019 Mar 5;8(5):e011112. doi: 10.1161/JAHA.118.011112
Lee HF,et al. - End Stage Renal Disease Patients Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers May Reduce the Risk of Mortality: A Taiwanese Nationwide Cohort Study
Intern Med J. 2018 May 29. doi: 10.1111/imj.13971.
Lee HF, et al. - The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation.
Int J Cardiol. 2018 Jun 15;261:78-83. doi: 10.1016/j.ijcard.2018.03.063.
Lee HF, et al. - Response to Letter to the Editor
J Formos Med Assoc. 2018 May;117(5):456. doi: 10.1016/j.jfma.2017.12.003. Epub 2018 Feb 13.
Lee HF, et al - Crusade Microcatheter-Facilitated Reverse Wire Technique for Revascularization of Bifurcation Lesions of Coronary Arteries.
Acta Cardiol Sin. 2018 Jan;34(1):31-36
Lee HF, et al. - Low bone mineral density may be associated with long-term risk of cancer in the middle-aged population: A retrospective observational study from a single center.
J Formos Med Assoc. 2018 Apr;117(4):339-345. doi: 10.1016/j.jfma.2017.04.021
Lee HF, et al - Impact of Chronic Kidney Disease on Long -term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention.
Korean Circ J. 2017 Jan;47(1):50-55. doi: 10.4070/kcj.2016.0093.
Peng JR, Chang CJ, Wang CL, Tung YC, Lee HF(通訊作者).. - Using Rivaroxaban as Thrombolytic Treatment for a Patient of Pedal Arch Arterial Thrombosis with Suboptimal Result of Endovascular Therapy.
Acta Cardiol Sin. 2016 Sep;32(5):623-626.
Lee HF*, et al. - Dialysis Patients with Implanted Drug-Eluting Stents Have Lower Major Cardiac Events and Mortality than Those with Implanted Bare-Metal Stents: A Taiwanese Nationwide Cohort Study.
PLoS One. 2016 Jan 5;11(1):e0146343. doi: 10.1371/journal.pone.0146343.
Lee HF, et al. - Prognostic significance of dilated inferior vena cava in advanced decompensated heart failure.
Int J Cardiovasc Imaging. 2014 Oct;30(7):1289-95. doi: 10.1007/s10554-014-0468-y.
Lee HF, et al. - Prognostic value of global left ventricular strain for conservatively treated patients with symptomatic aortic stenosis.
J Cardiol. 2013;62:301-6.
Lee HF, et al. - Association of blood group A with coronary artery disease in young adults in Taiwan.
Intern Med. 2012;51:1815-20
Lee HF,et al.
- 僅列以第一作者或通訊作者身份所發表的文章